03.01.2015 Views

Programma - Società italiana di neurologia

Programma - Società italiana di neurologia

Programma - Società italiana di neurologia

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

27<br />

O<br />

T<br />

T<br />

O<br />

B<br />

R<br />

E<br />

•<br />

A<br />

R<br />

E<br />

A<br />

P<br />

O<br />

S<br />

T<br />

E<br />

R<br />

THERAPY: A PILOT STUDY<br />

F. PATTI, S. LO FERMO, V. CIMINO, S. MESSINA, E. D'AMICO, S. CAVALLI, C. LEONE, M.<br />

BELLAVIA, C. CAMERANO, M. ZAPPIA (Catania)<br />

867. NATALIZUMAB AND COGNITIVE IMPAIRMENT IN MULTIPLE SCLEROSIS:<br />

BENEFITS FROM TREATMENT<br />

G. PAVAN, S. LA GIOIA, M. ROTTOLI (Milano, Bergamo)<br />

868. STOPPING NATALIZUMAB THERAPY: WHAT HAPPENS. THE REBOUND<br />

MS CENTRE OF FIDENZA CASE REPORTS<br />

I. PESCI, S. MAGNANI, D. CARINI, L. MANNESCHI, A. GUARESCHI, E. MONTANARI<br />

(Fidenza - PR)<br />

869. PUTATIVE MARKERS OF COGNITIVE DECLINE IN MULTIPLE SCLEROSIS:<br />

NEURO PSYCHOLOGICAL TESTING AND QUANTITATIVE ELECTRO -<br />

ENCEPHALOGRAPHY ASSESSMENT<br />

E. PIETROLONGO, D. TRAVAGLINI, G. SEPEDE, M. ONOFRJ, V. DI TOMMASO, D. FARINA,<br />

A. LUGARESI, G. DE LUCA (Chieti)<br />

870. COGNITIVE PERFORMANCE AND QUANTITATIVE MAGNETIC<br />

RESONANCE FEATURES IN MULTIPLE SCLEROSIS PATIENTS TREATED<br />

WITH NATALIZUMAB<br />

E. PORTACCIO, B. GORETTI, M. STROMILLO, V. ZIPOLI, A. GIORGIO, B. HAKIKI, M.<br />

BARTOLOZZI, L. GUIDI, M. GIANNINI, L. PASTÒ, L. RAZZOLINI, G. SIRACUSA, S. SORBI,<br />

A. FEDERICO, N. DE STEFANO, M. AMATO (Firenze, Siena, Empoli - FI)<br />

871. CLINICAL, SEROLOGICAL AND NEURORADIOLOGICAL CHARAC -<br />

TERISATION OF RECURRENT MYELITIS: IDENTIFICATION OF POSSIBLE<br />

PROGNOSTIC FACTORS<br />

M. RADAELLI, V. MARTINELLI, D. DALLA LIBERA, L. MOIOLA, D. PRIVITERA, F.<br />

MARTINELLI BONESCHI, M. RODEGHER, F. SANGALLI, R. FAZIO, G. COMI (Milano)<br />

872. RELAPSING NEUROMYELITIS OPTICA: CLINICAL CHARACTERISTICS<br />

AND IDENTIFICATION OF PROGNOSTIC FACTORS<br />

M. RADAELLI, D. DALLA LIBERA, L. MOIOLA, D. PRIVITERA, F. MARTINELLI BONESCHI,<br />

B. COLOMBO, F. SANGALLI, R. FAZIO, G. COMI, V. MARTINELLI (Milano)<br />

873. OVERCOMING THE CLINICAL-MRI PARADOX OF MS: MRI DATA ASSESSED<br />

WITH A RANDOM FOREST APPROACH<br />

M.A. ROCCA, K. KACAR, M. COPETTI, S. SALA, S. MESAROS, T. STOSIC OPINCAL, D.<br />

CAPUTO, M. ABSINTA, J. DRULOVIC, V. KOSTI, G. COMI, M. FILIPPI (Milano, S.<br />

Giovanni Rotondo - FG, Belgrado - SRB)<br />

874. STARTING IMMUNOMODULANTS SHORTLY AFTER NATALIZUMAB<br />

DISCONTINUATION: INITIAL IMPRESSIONS<br />

F. SANGALLI, L. MOIOLA, M. RADAELLI, V. BARCELLA, V. MARTINELLI, G. COMI (Milano)<br />

875. THE THINNING OF RETINAL NERVE FIBER LAYER IS ASSOCIATED<br />

WITH EXECUTIVE FUNCTION IMPAIRMENT IN MULTIPLE SCLEROSIS<br />

C. SENESI, G. FERRARI, P. IMMOVILLI, F. SALICI, S. MAINI, C. MACALUSO, F. GRANELLA<br />

(Parma, Boston - USA, Piacenza)<br />

876. A MULTIPLE SCLEROSIS RELAPSE PRESENTING AS PAROXYSMAL<br />

HEMIDYSTONIA<br />

A.M. SIMONE, D. FERRARO, E. MERELLI, P. NICHELLI, P. SOLA (Modena)<br />

877. INFORMATION PREFERENCE OF NEWLY-DIAGNOSED MS PATIENTS:<br />

PROSPECTIVE ASSESSMENT WITHIN THE SIMS-TRIAL<br />

A. SOLARI, A. GIORDANO, M. TROJANO, V. MARTINELLI, A. LUGARESI, F. GRANELLA, P.<br />

CONFALONIERI, C. TORTORELLA, I. PLASMATI, M. RADAELLI, D. FARINA, E. DALLA<br />

BELLA, L. MAGGI, M. MESSMER UCCELLI, E. PUCCI, C. BORREANI, R. D'ALESSANDRO<br />

(Milano, Bari, Chieti, Parma, Genova, Macerata, Bologna)<br />

216

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!